| scholarly article | Q13442814 |
| P2093 | author name string | Douglas S Lee | |
| Kumaraswamy Nanthakumar | |||
| Peter C Austin | |||
| Xuesong Wang | |||
| Hadas D Fischer | |||
| Andrew C T Ha | |||
| Andreu Porta-Sánchez | |||
| Fahad Almehmadi | |||
| P2860 | cites work | Prognostic importance of defibrillator shocks in patients with heart failure | Q24631203 |
| Current evidence base for use of the implantable cardioverter-defibrillator | Q27005963 | ||
| A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias | Q33175452 | ||
| Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators | Q36057430 | ||
| 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing | Q36594611 | ||
| Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Subs | Q38379450 | ||
| Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). | Q38425221 | ||
| The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice | Q38590651 | ||
| Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye? | Q39853163 | ||
| Incidence of Implantable Cardioverter Defibrillator Therapy and Mortality in Primary and Secondary Prevention of Sudden Cardiac Death | Q39981702 | ||
| Effect of ICD Therapies on Mortality in the OMNI Trial | Q40392631 | ||
| Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry | Q40638693 | ||
| Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial | Q42647214 | ||
| Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. | Q43149303 | ||
| Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact | Q43848349 | ||
| Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients | Q44474787 | ||
| Survival after implantable cardioverter-defibrillator implantation in the elderly | Q44664538 | ||
| Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario | Q47361963 | ||
| Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. | Q49168539 | ||
| Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. | Q50967484 | ||
| Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications. | Q53078770 | ||
| Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study. | Q53429962 | ||
| Response to letter regarding article, "Survival after implantable cardioverter-defibrillator implantation in the elderly". | Q53622511 | ||
| 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure | Q57629858 | ||
| Survival of antiarrhythmic or implantable cardioverter defibrillator treated patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias | Q74437818 | ||
| P433 | issue | 8 | |
| P921 | main subject | defibrillator | Q1450682 |
| P577 | publication date | 2017-08-19 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry | |
| P478 | volume | 6 |
| Q51731775 | Cardiac resynchronization therapy is associated with a reduction in ICD therapies, while improves ventricular function. |
| Q89768490 | Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33) |
| Q42354484 | Paradox of Appropriate Implantable Cardioverter-Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk |
Search more.